Skip to content

Social & QoL Behaviors in Parkinson's Disease

Social Behaviors and Quality of Life in Individuals With Parkinson's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06385184
Enrollment
500
Registered
2024-04-25
Start date
2024-03-08
Completion date
2027-12-31
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.

Interventions

OTHERNo Intervention

Observational study with no intervention

Sponsors

Gregory Wallace
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Parkinson's disease group Inclusion Criteria: * Have been diagnosed with Parkinsons Disease by a healthcare professional * Are at least 40 years old

Exclusion criteria

* Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome) Neurotypical group Inclusion Criteria: * Are at least 40 years old

Design outcomes

Primary

MeasureTime frameDescription
Subjective Quality of Lifethrough study completion, an average of 1 yearsatisfaction with different aspects of life, such as health and social relationships
Social Behaviorthrough study completion, an average of 1 yearability to interact with others
Activities of Daily Livingthrough study completion, an average of 1 yearability to complete tasks to be independent
Mental Healththrough study completion, an average of 1 yeardepression and anxiety symptoms
Cognitionthrough study completion, an average of 1 yearmemory and executive function challenges and strengths

Countries

United States

Contacts

CONTACTGregory Wallace, PhD
ladn@gwu.edu202-994-8285
PRINCIPAL_INVESTIGATORGregory Wallace, PhD

George Washington University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026